Published in Ann Oncol on January 01, 1999
Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer (1988) 4.03
Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed (2001) 2.29
Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood (1996) 2.08
The preparation and execution of self-initiated and externally-triggered movement: a study of event-related fMRI. Neuroimage (2002) 2.01
Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology (1999) 1.98
Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses (1995) 1.92
Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet (1997) 1.76
Fractal analysis: an objective method for identifying atypical nuclei in dysplastic lesions of the cervix uteri. Gynecol Oncol (1999) 1.74
Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant (2011) 1.73
Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation (1995) 1.71
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis. Leukemia (2005) 1.70
Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med (1997) 1.66
[Polyneuropathy following methaqualone (preliminary note)]. Nervenarzt (1973) 1.64
High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr (2000) 1.57
Finger somatotopy in human motor cortex. Neuroimage (2001) 1.53
Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol (2001) 1.51
Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Aliment Pharmacol Ther (2012) 1.47
Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy. Eur J Endocrinol (1995) 1.45
A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004. Epidemiol Infect (2006) 1.43
Fuzzy clustering of gradient-echo functional MRI in the human visual cortex. Part I: reproducibility. J Magn Reson Imaging (1998) 1.42
Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo. Magn Reson Med (2009) 1.40
Improved automated leucocyte counting and differential in newborns achieved by the haematology analyser CELL-DYN 3500. Clin Lab Haematol (1995) 1.40
An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant (1996) 1.38
Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37
Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37
[Methodological openness as the basis of integrative psychotherapy]. Psychother Psychosom Med Psychol (2000) 1.34
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome. Bone Marrow Transplant (2004) 1.34
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology (2001) 1.32
Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med (2001) 1.32
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer (2001) 1.30
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning. Leukemia (2003) 1.30
Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients. Bone Marrow Transplant (2009) 1.29
IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett (1996) 1.29
Effect of local low-dose thrombolysis on clinical outcome in acute embolic renal artery occlusion. Radiology (1993) 1.27
Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg (1996) 1.24
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia (2011) 1.24
A hierarchical clustering method for analyzing functional MR images. Magn Reson Imaging (1999) 1.23
Optimized 3 T EPI of the amygdalae. Neuroimage (2004) 1.23
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Leukemia (2012) 1.23
1H NMR relaxation times of skeletal muscle metabolites at 3 T. MAGMA (2004) 1.22
Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. Cell Mol Biol (Noisy-le-grand) (1997) 1.22
Quantification in functional magnetic resonance imaging: fuzzy clustering vs. correlation analysis. Magn Reson Imaging (1998) 1.22
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET? Ann Oncol (2005) 1.21
Sequence determination of the 3' end of mouse mammary tumor virus RNA. Mol Biol Rep (1981) 1.21
A limit on the variation of the speed of light arising from quantum gravity effects. Nature (2009) 1.20
Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. Blood (1995) 1.19
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol (2005) 1.18
Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18
Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology (2001) 1.17
Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes (1999) 1.16
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med (2001) 1.15
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging (2004) 1.13
Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J Immunol (1996) 1.13
Fully exploratory network ICA (FENICA) on resting-state fMRI data. J Neurosci Methods (2010) 1.12
Hoffa fracture--a radiologic diagnostic approach. J Belge Radiol (1996) 1.10
Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol (1999) 1.09
Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis (2000) 1.08
[Clarithromycin for monotherapy of B-cell MALT lymphoma?]. Ophthalmologe (2013) 1.08
Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment. NMR Biomed (2008) 1.07
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. Bone Marrow Transplant (2009) 1.07
Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood (1996) 1.07
Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy. Ann Oncol (2007) 1.06
LBBB: challenging our concept of metabolic heart imaging with fluorine-18-FDG and PET? J Nucl Med (1998) 1.06
Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transplant (2007) 1.06
MRI-diffusion imaging of neuroblastomas: first results and correlation to histology. Eur Radiol (2002) 1.04
Dynamic interleaved 1H/31P STEAM MRS at 3 Tesla using a pneumatic force-controlled plantar flexion exercise rig. MAGMA (2005) 1.03
A comparative study on the frequency of prophages among natural isolates of Salmonella and Escherichia coli with emphasis on generalized transducers. Antonie Van Leeuwenhoek (1998) 1.03
A wavelet-based method for improving signal-to-noise ratio and contrast in MR images. Magn Reson Imaging (2000) 1.03
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis (2001) 1.02
MR imaging of the carpal tunnel. Eur J Radiol (1997) 1.02
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla. J Psychiatr Res (1999) 1.01
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant (2004) 1.01
Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol (2007) 1.01
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives. Bone Marrow Transplant (2004) 1.00
Evidence for premotor cortex activity during dynamic visuospatial imagery from single-trial functional magnetic resonance imaging and event-related slow cortical potentials. Neuroimage (2001) 0.99
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia (2011) 0.99
The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation. Leuk Lymphoma (1998) 0.99
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report. Cancer Res (1994) 0.98
Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. Eur J Radiol (2007) 0.98
Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J Immunol (1999) 0.98
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting. Bone Marrow Transplant (2009) 0.98
A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation? Leukemia (2009) 0.97
Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant (2003) 0.97
Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2012) 0.97
Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol (1996) 0.97